Biofrontera, Inc. (NASDAQ:BFRI) Q3 2022 Earnings Conference Call November 14, 2022 11:00 AM ET

Company Participants

Tirth Patel - LHA Investor Relations

Fred Leffler - CFO

Erica Monaco - CEO, COO, Treasurer & Secretary

Conference Call Participants

Jonathan Aschoff - ROTH Capital Partners

Bruce Jackson - The Benchmark Company

Operator

Good day, and welcome to the Biofrontera Inc. Third Quarter Earnings Conference Call. [Operator Instructions]. Please note, this event is being recorded. I would now like to turn the conference over to Tirth Patel of Investor Relations. Please go ahead.

Tirth Patel

Good morning, and welcome to Biofrontera Inc.'s Third Quarter 2022 Financial Results and Business Update Conference Call. Please note that certain information discussed during today's call by management is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that Biofrontera's management will be making forward-looking statements and that actual results may differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. All risks and uncertainties are detailed in and qualified by the cautionary statements contained in Biofrontera's press releases and SEC filings.

Also, this conference call contains time-sensitive information that is accurate only as of the date of the live broadcast today, November 14, 2022. Biofrontera undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as required by law.

During today's call, there will be references to certain non-GAAP financial measures. Biofrontera believes these measures provide useful information for investors, yet should not be considered as a substitute for GAAP nor should they be viewed as a substitute for operating results determined in accordance with GAAP. A reconciliation of non-GAAP to GAAP results is included in this morning's press release. More specifically, management will be referencing adjusted EBITDA, a non-GAAP financial measure defined as net income or loss excluding interest income and expense, income taxes, depreciation, amortization and certain other nonrecurring or noncash items.

With that, I would like to turn the call over to Erica Monaco, Chief Executive Officer of Biofrontera Inc. Erica?

Erica Monaco

Thank you, Tirth, and welcome, everyone, to our third quarter conference call. Joining me today is Fred Leffler, our newly appointed Chief Financial Officer. In a moment, Fred will review our recent financial results, and then I'll discuss the business and strategy. But first, I'd like to say a few words.